CA Patent

CA3155066A1 — Fused pyridone compound, and preparation method therefor and use thereof

Assigned to Jiangxi Jemincare Group Co Ltd · Expires 2021-03-25 · 5y expired

What this patent protects

Disclosed in the present invention are a fused pyridone compound, and a preparation method therefor and a use thereof. Specifically, the present invention discloses a compound of formula (I-B), an optical isomer thereof and a pharmaceutically acceptable salt thereof, and the use …

USPTO Abstract

Disclosed in the present invention are a fused pyridone compound, and a preparation method therefor and a use thereof. Specifically, the present invention discloses a compound of formula (I-B), an optical isomer thereof and a pharmaceutically acceptable salt thereof, and the use of the compound as a KRAS inhibitor.

Drugs covered by this patent

Patent Metadata

Patent number
CA3155066A1
Jurisdiction
CA
Classification
—
Expires
2021-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Jiangxi Jemincare Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.